Annual report pursuant to Section 13 and 15(d)

Stock Options and Warrants (Tables)

v3.23.1
Stock Options and Warrants (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Stock options outstanding
           
    Options    

Weighted Avg.

Exercise Price

 
Options outstanding, December 31, 2020     32,480,601     $ 0.18  
Options granted     800,000       0.03  
Options exercised            
Options cancelled     (2,200,000 )     0.30  
Options outstanding, December 31, 2021     31,080,601     $ 0.17  
Options granted            
Options exercised     (250,000 )     0.08  
Options cancelled     (4,773,000 )     0.26  
Options outstanding, December 31, 2022     26,057,601     $ 0.15  
Schedule of options outstanding by per share price
                             
    Outstanding Options     Exercisable Options  
Option
Exercise Price
Per Share
  Shares     Life
(Years)
    Weighted
Average
Exercise Price
    Shares     Weighted
Average Exercise
Price
 
$0.02 - $0.24     22,055,551       5.1     $ 0.10       22,055,551     $ 0.10  
$0.25 - $0.49     3,388,552       3.6       0.36       3,388,552       0.36  
$0.50 - $0.99     463,052       1.4       0.85       463,052       0.85  
$1.00 - $2.00     150,446       0.6       1.18       150,446       1.18  
      26,057,601       4.8     $ 0.15       26,057,601     $ 0.15  
Assumptions used for option valuation
           
    Years Ended  
    2022     2021  
Expected life (years)           4.9  
Risk free interest rate           1.3%  
Volatility           148%  
Expected dividend yield           0%  
Schedule of warrant activity
           
    Warrants    

Weighted Avg.

Exercise Price

 
Warrants outstanding, December 31, 2020     8,683,677     $ 0.11  
Warrants granted     19,307,153       0.04  
Warrants exercised            
Warrants cancelled     (8,013,681 )     0.10  
Warrants outstanding, December 31, 2021     19,977,149     $ 0.04  
Warrants granted     16,426,657       0.04  
Warrants exercised     (14,483,825 )     0.04  
Warrants cancelled     (1,605,828 )     0.04  
Warrants outstanding, December 31, 2022     20,314,153     $ 0.04  
Schedule of warrants outstanding by per share price
                             
    Outstanding Warrants     Exercisable Warrants  
Option
Exercise Price
Per Share
  Shares     Life
(Years)
    Weighted
Average
Exercise Price
    Shares     Weighted
Average Exercise
Price
 
$0.02 - $0.24     20,244,153       1.0     $ 0.04       20,210,820     $ 0.04  
$0.25 - $0.49                              
$0.50 - $1.00     70,000       1.3       0.80       70,000       0.80  
$1.00 - $2.00                              
      20,314,153       1.0     $ 0.04       20,280,820     $ 0.04  

 

Year Ending December 31, 2022

 

  · In September 2022, pursuant to terms of convertible notes issued, the Company granted warrants to purchase 14,409,995 shares of common stock with an exercise price of $0.04 per share, vesting immediately upon grant and expiring one year from the date of grant. See Note 5 for further discussion.
     
  · In January through December 2022, pursuant to terms of consulting agreements, the Company granted warrants to purchase 2,016,662 shares of common stock with an exercise price of $0.02 to $0.09 per share, vesting up to one month from the date of grant and expiring two to five years from the date of grant. Total fair value of these options at grant date was approximately $127,000 determined using the Black-Scholes Option Pricing model with the following assumptions: life of 2 to 5 years; risk free interest rate of 0.13% to 4.49%; volatility of 193% to 245%; and dividend yield of 0%. During the year ended December 31, 2021, the Company recognized compensation expense of $127,000 based on the fair value of the warrants that vested.

 

Year Ending December 31, 2021

  

  · In February through December 2021, pursuant to terms of convertible notes issued, the Company granted warrants to purchase 18,907,157 shares of common stock with an exercise price of $0.03 to $0.04 per share, vesting immediately upon grant and expiring one year from the date of grant. See Note 5 for further discussion.
     
  · In January through December 2021, pursuant to terms of a consulting agreement, the Company granted warrants to purchase 399,996 shares of common stock with an exercise price of $0.02 to $0.05 per share, vesting one month from the date of grant and expiring two years from the date of grant. Total fair value of these options at grant date was approximately $13,000 determined using the Black-Scholes Option Pricing model with the following assumptions: life of 2 years; risk free interest rate of 0.11% to 0.7%; volatility of 204% to 242%; and dividend yield of 0%. During the year ended December 31, 2021, the Company recognized compensation expense of $13,000 based on the fair value of the warrants that vested.